Literature DB >> 26848157

Platelet Control of Fibrin Distribution and Microelasticity in Thrombus Formation Under Flow.

Frauke Swieringa1, Constance C F M J Baaten1, Remco Verdoold1, Tom G Mastenbroek1, Niek Rijnveld1, Koen O van der Laan1, Ernst J Breel1, Peter W Collins1, Marcus D Lancé1, Yvonne M C Henskens1, Judith M E M Cosemans1, Johan W M Heemskerk1, Paola E J van der Meijden2.   

Abstract

OBJECTIVE: Platelet- and fibrin-dependent thrombus formation is regulated by blood flow and exposure of collagen and tissue factor. However, interactions between these blood-borne and vascular components are not well understood. APPROACH AND
RESULTS: Here, we developed a method to assess whole-blood thrombus formation on microspots with defined amounts of collagen and tissue factor, allowing determination of the mechanical properties and intrathrombus composition. Confining the collagen content resulted in diminished platelet deposition and fibrin formation at high shear flow conditions, but this effect was compensated by a larger thrombus size and increased accumulation of fibrin in the luminal regions of the thrombi at the expense of the base regions. These thrombi were more dependent on tissue factor-triggered thrombin generation. Microforce nanoindentation analysis revealed a significantly increased microelasticity of thrombi with luminal-oriented fibrin. At a low shear rate, fibrin fibers tended to luminally cover the thrombi, again resulting in a higher microelasticity. Studies with blood from patients with distinct hemostatic insufficiencies indicated an impairment in the formation of a platelet-fibrin thrombus in the cases of dilutional coagulopathy, thrombocytopenia, Scott syndrome, and hemophilia B.
CONCLUSIONS: Taken together, our data indicate that (1) thrombin increases the platelet thrombus volume; (2) tissue factor drives the formation of fibrin outside of the platelet thrombus; (3) limitation of platelet adhesion redirects fibrin from bottom to top of the thrombus; (4) a lower shear rate promotes thrombus coverage with fibrin; (5) the fibrin distribution pattern determines thrombus microelasticity; and (6) the thrombus-forming process is reduced in patients with diverse hemostatic defects.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  blood platelet; elasticity; fibrin; thrombin; thrombosis

Mesh:

Substances:

Year:  2016        PMID: 26848157     DOI: 10.1161/ATVBAHA.115.306537

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  23 in total

Review 1.  Thrombotic Regulation From the Endothelial Cell Perspectives.

Authors:  Miao Wang; Huifeng Hao; Nicholas J Leeper; Liyuan Zhu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-06       Impact factor: 8.311

2.  Platelet heterogeneity in activation-induced glycoprotein shedding: functional effects.

Authors:  Constance C F M J Baaten; Frauke Swieringa; Tomasz Misztal; Tom G Mastenbroek; Marion A H Feijge; Paul E Bock; Marjo M P C Donners; Peter W Collins; Renhao Li; Paola E J van der Meijden; Johan W M Heemskerk
Journal:  Blood Adv       Date:  2018-09-25

Review 3.  Fibrin Formation, Structure and Properties.

Authors:  John W Weisel; Rustem I Litvinov
Journal:  Subcell Biochem       Date:  2017

Review 4.  Fibrinogen and Fibrin in Hemostasis and Thrombosis.

Authors:  Sravya Kattula; James R Byrnes; Alisa S Wolberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03       Impact factor: 8.311

5.  Structural control of fibrin bioactivity by mechanical deformation.

Authors:  Sachin Kumar; Yujen Wang; Mohammadhasan Hedayati; Frederik Fleissner; Manuel K Rausch; Sapun H Parekh
Journal:  Proc Natl Acad Sci U S A       Date:  2022-05-25       Impact factor: 12.779

6.  Flow studies on human GPVI-deficient blood under coagulating and noncoagulating conditions.

Authors:  Magdolna Nagy; Gina Perrella; Amanda Dalby; M Francisca Becerra; Lourdes Garcia Quintanilla; Jeremy A Pike; Neil V Morgan; Elizabeth E Gardiner; Johan W M Heemskerk; Lorena Azócar; Juan Francisco Miquel; Diego Mezzano; Steve P Watson
Journal:  Blood Adv       Date:  2020-07-14

7.  Reversing direct factor Xa or thrombin inhibitors: Factor V addition to prothrombin complex concentrate is beneficial in vitro.

Authors:  Herm Jan M Brinkman; Frauke Swieringa; Marleen Zuurveld; Alicia Veninga; Sanne L N Brouns; Johan W M Heemskerk; Joost C M Meijers
Journal:  Res Pract Thromb Haemost       Date:  2022-04-25

8.  Platelet-primed interactions of coagulation and anticoagulation pathways in flow-dependent thrombus formation.

Authors:  Sanne L N Brouns; Johanna P van Geffen; Elena Campello; Frauke Swieringa; Paolo Simioni; Johan W M Heemskerk; Luca Spiezia; René van Oerle; Isabella Provenzale; Remco Verdoold; Richard W Farndale; Kenneth J Clemetson; Henri M H Spronk; Paola E J van der Meijden; Rachel Cavill; Marijke J E Kuijpers; Elisabetta Castoldi
Journal:  Sci Rep       Date:  2020-07-17       Impact factor: 4.379

9.  Suppressive Role of Tissue Factor Pathway Inhibitor-α in Platelet-Dependent Fibrin Formation under Flow Is Restricted to Low Procoagulant Strength.

Authors:  Stella Thomassen; Tom G Mastenbroek; Frauke Swieringa; Kristien Winckers; Marion A H Feijge; Roy Schrijver; Judith M E M Cosemans; Susan A Maroney; Alan E Mast; Tilman M Hackeng; Johan W M Heemskerk
Journal:  Thromb Haemost       Date:  2018-02-16       Impact factor: 5.249

Review 10.  Integrating platelet and coagulation activation in fibrin clot formation.

Authors:  Frauke Swieringa; Henri M H Spronk; Johan W M Heemskerk; Paola E J van der Meijden
Journal:  Res Pract Thromb Haemost       Date:  2018-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.